Apotex patents expiration
1. Melphalan Hydrochloride patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10537520 | APOTEX | Stable liquid formulations of melphalan |
Jun, 2036
(12 years from now) | |
Drugs and Companies using MELPHALAN HYDROCHLORIDE ingredient
Market Authorisation Date: 18 August, 2023
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
MELPHALAN HYDROCHLORIDE family patents
2. Paxil patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6113944 | APOTEX | Paroxetine tablets and process to prepare them |
Dec, 2014
(9 years ago) | |
| US5900423 | APOTEX | Form of paroxetine hydrochloride anhydrate |
May, 2015
(8 years ago) | |
| US6080759 | APOTEX | Paroxetine hydrochloride form A |
May, 2015
(8 years ago) | |
| US5872132 | APOTEX | Form of paroxetine hydrochloride anhydrate |
May, 2015
(8 years ago) | |
| US6133289 | APOTEX | Paroxetine hydrochloride form A or C |
May, 2015
(8 years ago) | |
|
US6113944 (Pediatric) | APOTEX | Paroxetine tablets and process to prepare them |
Jun, 2015
(8 years ago) | |
| US5811436 | APOTEX | Oral liquid compositions containing paroxetine resinate |
Sep, 2015
(8 years ago) | |
|
US5872132 (Pediatric) | APOTEX | Form of paroxetine hydrochloride anhydrate |
Nov, 2015
(8 years ago) | |
|
US5900423 (Pediatric) | APOTEX | Form of paroxetine hydrochloride anhydrate |
Nov, 2015
(8 years ago) | |
|
US6080759 (Pediatric) | APOTEX | Paroxetine hydrochloride form A |
Nov, 2015
(8 years ago) | |
|
US6133289 (Pediatric) | APOTEX | Paroxetine hydrochloride form A or C |
Nov, 2015
(8 years ago) | |
|
US5811436 (Pediatric) | APOTEX | Oral liquid compositions containing paroxetine resinate |
Mar, 2016
(8 years ago) | |
| US6121291 | APOTEX | Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder |
Mar, 2017
(7 years ago) | |
|
US6121291 (Pediatric) | APOTEX | Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder |
Sep, 2017
(6 years ago) | |
| US6172233 | APOTEX | Process for making paroxetine |
Jan, 2018
(6 years ago) | |
|
US6172233 (Pediatric) | APOTEX | Process for making paroxetine |
Jul, 2018
(5 years ago) | |
| US6063927 | APOTEX | Paroxetine derivatives |
Apr, 2019
(5 years ago) | |
|
US6063927 (Pediatric) | APOTEX | Paroxetine derivatives |
Oct, 2019
(4 years ago) | |
Drugs and Companies using PAROXETINE HYDROCHLORIDE ingredient
Market Authorisation Date: 29 December, 1992
Treatment: Depression, obsessive compulsive disorder, panic disorder and social anxiety disorder; Depression
Dosage: TABLET;ORAL; CAPSULE;ORAL; SUSPENSION;ORAL
PAXIL family patents
3. Paxil Cr patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US5422123 (Pediatric) | APOTEX | Tablets with controlled-rate release of active substances |
Dec, 2012
(11 years ago) | |
| US6133289 | APOTEX | Paroxetine hydrochloride form A or C |
May, 2015
(8 years ago) | |
| US5872132 | APOTEX | Form of paroxetine hydrochloride anhydrate |
May, 2015
(8 years ago) | |
| US5900423 | APOTEX | Form of paroxetine hydrochloride anhydrate |
May, 2015
(8 years ago) | |
|
US6133289 (Pediatric) | APOTEX | Paroxetine hydrochloride form A or C |
Nov, 2015
(8 years ago) | |
|
US5872132 (Pediatric) | APOTEX | Form of paroxetine hydrochloride anhydrate |
Nov, 2015
(8 years ago) | |
|
US5900423 (Pediatric) | APOTEX | Form of paroxetine hydrochloride anhydrate |
Nov, 2015
(8 years ago) | |
| US6548084 | APOTEX | Controlled release compositions |
Jul, 2016
(7 years ago) | |
| US7229640 | APOTEX | Paroxetine controlled release compositions |
Jul, 2016
(7 years ago) | |
|
US6548084 (Pediatric) | APOTEX | Controlled release compositions |
Jan, 2017
(7 years ago) | |
|
US7229640 (Pediatric) | APOTEX | Paroxetine controlled release compositions |
Jan, 2017
(7 years ago) | |
| US6121291 | APOTEX | Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder |
Mar, 2017
(7 years ago) | |
|
US6121291 (Pediatric) | APOTEX | Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder |
Sep, 2017
(6 years ago) | |
Drugs and Companies using PAROXETINE HYDROCHLORIDE ingredient
Market Authorisation Date: 16 February, 1999
Treatment: Depression; Depression, panic disorder, premenstrual disorders and social anxiety disorder
Dosage: TABLET, EXTENDED RELEASE;ORAL
PAXIL CR family patents